Vivian Mo, MD

Title(s)Clinical Associate Professor of Medicine (Clinician Educator)
Phone+1 323 442 6130
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    1995LEXIA Scholarship
    Psi Chi Honor Society1996Excellence in Psychology
    Houston International Fund1996Scholarship
    University of Texas- Southwestern Medical Center2003Nomination for Outstanding Clinical Medicine Resident
    2007Charles S. Houston Award

    Collapse Overview 
    Collapse Overview
    Dr. Vivian Mo is a Clinical Associate Professor of Medicine and specializes in cardiology and echocardiography. She completed her internship and residency in internal medicine and a fellowship in cardiology at the University of Texas - Southwestern Medical Center in Dallas. Currently she is the Chief Medical Officer of USC Care Medical Group, Director of the Women's Cardiovascular Center of USC and is an active medical educator by serving as Clinical Associate Professor of Medicine to the cardiovascular medicine fellowship program. While at USC, Dr. Mo has continued her research in the fields of preventive cardiology, echocardiography and cardiovascular disease in women. She currently serves as a co-investigator on a study which addresses carotid plaque composition by MRI while on statin therapy. She is also a site principal investigator for the VIRGO study which examines why outcomes of women differ from those of men in acute myocardial infarctions. Dr. Mo is a Fellow of the American College of Cardiology and American Society of Echocardiography, and a member of the American Heart Association.

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Ge RL, Mo VY, Januzzi JL, Jin G, Yang Y, Han S, Wood MJ, Levine BD. B-type natriuretic peptide, vascular endothelial growth factor, endothelin-1, and nitric oxide synthase in chronic mountain sickness. Am J Physiol Heart Circ Physiol. 2011 Apr; 300(4):H1427-33. PMID: 21217075.
      View in: PubMed
    2. Kollipara UK, Mo V, Toto KH, Nelson LL, Schneider RA, Neily JB, Drazner MH. High-sodium food choices by southern, urban African Americans with heart failure. J Card Fail. 2006 Mar; 12(2):144-8. PMID: 16520264.
      View in: PubMed
    3. Mo VY, de Lemos JA. The use of MCP-1 and soluble CD40 ligand in a pathophysiology-guided approach to the management of coronary artery disease. Future Cardiol. 2005 Sep; 1(5):649-56. PMID: 19804105.
      View in: PubMed
    4. Mo VY, De Lemos JA. Individualizing therapy in acute coronary syndromes: using a multiple biomarker approach for diagnosis, risk stratification, and guidance of therapy. Curr Cardiol Rep. 2004 Jul; 6(4):273-8. PMID: 15182604.
      View in: PubMed
    5. Greenberg JS, El Naggar AK, Mo V, Roberts D, Myers JN. Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma. Implication for therapeutic decision making. Cancer. 2003 Aug 01; 98(3):508-15. PMID: 12879467.
      View in: PubMed
    6. Greenberg JS, Fowler R, Gomez J, Mo V, Roberts D, El Naggar AK, Myers JN. Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer. 2003 Mar 15; 97(6):1464-70. PMID: 12627511.
      View in: PubMed
    7. Myers JN, Greenberg JS, Mo V, Roberts D. Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer. 2001 Dec 15; 92(12):3030-6. PMID: 11753980.
      View in: PubMed